A recent study highlights the sex-specific molecular mechanisms underlying lower urinary tract dysfunction (LUTD) in aging, particularly its disproportionate impact on women. Conducted as part of the NIH Common Fund SenNet program, researchers investigated the effects of a senolytic drug combination, Dasatinib and Quercetin (D&Q), on bladder health in aged mice. They found significant baseline differences in the unfolded protein response (UPR) and ER-associated degradation (ERAD) proteins between male and female bladders, with females exhibiting heightened ER stress markers.

The study’s findings are crucial for the longevity and healthspan field as they suggest that the aging bladder’s response to cellular senescence and oxidative stress may differ by sex. Notably, D&Q treatment selectively improved urothelial integrity in aged females, indicating potential therapeutic avenues for LUTD that account for sex differences in aging biology.

This research underscores the importance of considering sex as a biological variable in aging studies and opens the door for targeted interventions in LUTD, particularly for older women.

Source: academic.oup.com